Abstract:OBJECTIVENeonatal intrahepatic cholestasis caused by citrin deficiency (NICCD, OMIM #605814) is a novel autosomal recessive disease caused by mutations in the gene SLC25A13 that encodes for citrin, a liver-type aspartate/glutamate carrier located in the mitochondrial inner membrane. SLC25A13 was cloned in 1999 by Kobayashi et al at Kagoshima University in Japan, and until now, most of the NICCD patients reported in the world were Japanese. Most of the Chinese NICCD patients diagnosed by genetic analysis had the same SLC25A13 mutations as Japanese, however, in some cases, known mutations were not detected. This research aimed to identify novel SLC25A13 mutations in Chinese NICCD patients and to explore the experimental conditions for their genetic diagnosis.METHODSGenomic DNA was extracted from blood samples of 3 NICCD patients from Taiwan (P757), Guangdong (P1194) and Hebei province (P1443) of China, respectively, and all the 18 exons and their flanking sequences of SLC25A13 gene were sequenced. Furthermore, the identified novel mutations were diagnosed by amplification with PCR, digestion with corresponding restriction endonuclease, and agarose gel electrophoresis.RESULTSThree novel mutations identified in SLC25A13 gene of the 3 NICCD patients were an abnormal splicing IVS7-2A > G (P757), a missense A541D (c.1622C > A, P1194) and a nonsense R319X (c.955C > T, P1443). The PCR-restriction fragment length polymorphism (RFLP) procedures for their genetic diagnosis were also established, with specific fragments on electrophoresis after digestion of the PCR products with three different restriction endonucleases Msp I, Hpy188I and Taq I, respectively.CONCLUSIONSSo far as we know, the three novel mutations in SLC25A13 gene of Chinese NICCD patients were first identified, suggesting that SLC25A13 mutation distributed in Chinese population is somewhat different from that in Japanese. Moreover, the PCR-RFLP diagnostic procedures established in this research provide valuable tools not only for the genetic diagnosis of NICCD but also for further molecular epidemiologic investigations in Chinese population.

SLC25A13 Gene Analysis in Citrin Deficiency: Sixteen Novel Mutations in East Asian Patients, and the Mutation Distribution in a Large Pediatric Cohort in China

Molecular Diagnosis of Pediatric Patients with Citrin Deficiency in China: SLC25A13 Mutation Spectrum and the Geographic Distribution.

Frequency and Distribution in East Asia of 12 Mutations Identified in the Slc25a13 Gene of Japanese Patients with Citrin Deficiency

Identification of 13 Novel Mutations Including a Retrotransposal Insertion in SLC25A13 Gene and Frequency of 30 Mutations Found in Patients with Citrin Deficiency

Overview of Citrin Deficiency:SLC25A13 Mutations and the Frequency

[Identification and Diagnosis of Three Novel Mutations in SLC25A13 Gene of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency].

Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations.

Clinical, Molecular and Functional Investigation on an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD).

Screening for Five Prevalent Mutations of SLC25A13 Gene in Guangdong, China: a Molecular Epidemiologic Survey of Citrin Deficiency.

The mutation spectrum of the SLC25A13 gene in Chinese infants with intrahepatic cholestasis and aminoacidemia

[A Novel SLC25A13 Variant and the Resultant Aberrant Transcript Identified in a Pedigree Affected with Citrin Deficiency].

SLC25A13 Gene Mutation Analysis in a Pedigree of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency

Molecular Analysis of SLC25A13 Gene in Human Peripheral Blood Lymphocytes: Marked Transcript Diversity, and the Feasibility of Cdna Cloning As a Diagnostic Tool for Citrin Deficiency

Genotypic and Phenotypic Features of Citrin Deficiency: Five-Year Experience in A Chinese Pediatric Center

Clinical and Genetic Analysis of 26 Chinese Patients with Neonatal Intrahepatic Cholestasis Due to Citrin Deficiency.

Molecular Epidemiologic Study of Citrin Deficiency by Screening for Four Reported Pathogenic SLC25A13 Variants in the Shaanxi and Guangdong Provinces, China.

Analysis of SLC25A13 Gene Mutations and Prenatal Diagnosis for 20 Families Affected with Citrin Deficiency

Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency: In vivo and in vitro studies of the aberrant transcription arising from two novel splice-site variants in SLC25A13

Molecular Diagnosis of Citrin Deficiency in an Infant with Intrahepatic Cholestasis: Identification of a 21.7kb Gross Deletion That Completely Silences the Transcriptional and Translational Expression of the Affected SLC25A13 Allele.

Identification of Novel Mutations in Chinese Infants With Citrullinemia

Inspissated Bile Syndrome in an Infant with Citrin Deficiency and Congenital Anomalies of the Biliary Tract and Esophagus: Identification and Pathogenicity Analysis of a Novel SLC25A13 Mutation with Incomplete Penetrance.